Randall Wong, MD

Company: 4D Molecular Therapeutics

Job title: Medical Director

Seminars:

4D-150 Intravitreal Gene Therapy: Phase II Data 12:00 pm

Understanding the advantages of intravitreal injection platform to appreciate superior delivery method over competing approaches Examining the safety of 4D-150 from the Phase II wet AMD trial to recognize breakthrough safety profiles in gene therapy Exploring the scientific evidence behind customized capsids to understand why 4DMT has solved safety challenges where nobody else hasRead more

day: Conference Day One